RIL
NAGE

Rothschild Investment LLC’s Niagen Bioscience NAGE Stock Holding History

Rothschild Investment LLC’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.3K Buy
749
+674
+899% +$3.64K ﹤0.01% 2285
2025
Q4 		$477 Buy
75
+45
+150% +$313 ﹤0.01% 2933
2025
Q3 		$280 Sell
30
-85
-74% -$858 ﹤0.01% 2957
2025
Q2 		$1.66K Buy
+115
New +$1.14K ﹤0.01% 2188
2025
Q1 		– Sell
-40
Closed -$212 – 3102
2024
Q4 		$212 Buy
+40
New +$219 ﹤0.01% 2782

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rothschild Investment LLC's NAGE Position: Q1 2026 in Review

Rothschild Investment LLC increased its Niagen Bioscience (NAGE) stake by 899% in Q1 2026, buying an estimated $3.64K and bringing the position to 749 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

Rothschild Investment LLC first reported a position in NAGE in Q4 2024 and has held it in 5 quarters since. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Rothschild Investment LLC held 749 shares of Niagen Bioscience worth $3.3K as of Q1 2026.
  • Rothschild Investment LLC bought 674 Niagen Bioscience shares in Q1 2026, an estimated $3.64K.
  • Niagen Bioscience made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2285 holding.
  • Rothschild Investment LLC first reported a position in Niagen Bioscience in Q4 2024 and has held it in 5 quarters since.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.